CRCA is a single-stock leveraged exchange-traded fund that seeks daily investment results, before fees and expenses, corresponding to two times (2x) the daily performance of the Class A common shares of Circle Internet Group, best known for issuing the USDC stablecoin. The fund achieves this exposure primarily through swap agreements and other derivatives, with remaining assets in cash and short-term U.S. Treasury instruments.
It is non-diversified, holds roughly 15 positions, and carries a net expense ratio of 0.95%. Because it resets leverage daily, returns over periods longer than one day can diverge significantly from 2x the underlying stock's cumulative return due to volatility decay. This makes CRCA a tactical trading tool suited for short holding periods rather than a buy-and-hold investment, as it magnifies both gains and losses in Circle's shares. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the sector.
Over the trailing 30 days, CRCA declined approximately 27%, from about $17.63 to $12.81. The decline was not gradual, featuring pronounced daily swings, including a double-digit single-session drop tied to the underlying stock's selloff on security and competitive concerns.
The three-month picture looks different. From roughly $12.50 in late July, CRCA rallied toward a peak near $29 in early September before giving back the entire advance and finishing the period essentially flat at about $12.81. This round trip shows how daily rebalancing can erode value even when the underlying stock shows little net change over a longer window.
The recent drop largely reflects amplified weakness in Circle Internet Group. The most immediate shock was a security breach at Binance involving roughly $6.3 billion, disclosed in late October, after which Circle froze more than $800 million of USDC tied to the incident. While the freeze highlighted USDC's compliance safeguards, it coincided with a broad crypto-sector selloff.
Company-specific sentiment also weakened. Analysts at Mizuho reiterated an Underperform rating and cut their price target, warning that AI personal-assistant tools could steer users away from USDC toward higher-yielding, FDIC-insured bank accounts. This view came against stalled crypto market-structure legislation, with the CLARITY Act's progress in the Senate weighing on sentiment. From what I see, Circle's heavy reliance on reserve income makes these developments particularly impactful.
The broader three-month trend featured a sharp rally followed by an equally sharp reversal. The early-quarter advance reflected optimism around stablecoin adoption, Circle's regulatory positioning, and growth in USDC use cases. Three structural themes have since weighed on the position: the launch of Open USD, a rival stablecoin backed by a consortium including major payments and asset-management firms; expectations that U.S. interest rates may drift lower; and sustained weakness across crypto-linked equities.
These forces, combined with the fund's daily leverage reset, explain why the quarter ended roughly flat despite substantial interim volatility. I'm watching this closely as interest-rate sensitivity remains a core variable for Circle's earnings outlook.
Several factors are likely to shape CRCA over the coming months. The most important is interest rates, since Circle's reserve income scales directly with short-term yields. Equally significant is USDC circulation, which depends on stablecoin adoption, competitive dynamics from Open USD, and the regulatory environment. Investors should also monitor progress of stablecoin legislation such as the CLARITY Act, upcoming earnings reports, and broader crypto-market sentiment.
The fund's own mechanics matter as well: daily resets and high volatility mean multi-day holding periods can produce returns that diverge materially from 2x the underlying stock.
In my own research process, I often turn to Tickeron’s AI Screener when evaluating leveraged products like this one. It helps scan for technical indicators, fundamentals, volatility metrics, and price patterns across thousands of securities, which can surface ideas that complement manual analysis of single-stock ETFs where timing is critical. The platform lets users set custom criteria to match specific profiles, providing an efficient way to review opportunities in volatile names.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
CRCA saw its Momentum Indicator move below the 0 level on October 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator turned negative. In 24 of the 24 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for CRCA turned negative on October 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 8 similar instances when the indicator turned negative. In 7 of the 8 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.
CRCA moved below its 50-day moving average on September 29, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CRCA crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 2 of 2 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRCA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CRCA entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +4.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRCA advanced for three days, in 50 of 57 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
CRCA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Category Unknown